Clinical Trials · NCT02501850
The Effect of the GLP-1 Receptor Agonists on Blood Levels of Lipoprotein (a)
- Phase
- Phase 4
- Recruitment status
- Unknown
- Sponsor
- Hospital Universitari Vall d'Hebron Research Institute
- Enrollment
- 40
- Start date
- Oct 2014
- Locations
- 1 site, Spain
- Primary endpoint
- Change in blood levels of Lipoprotein (a) (Lp(a))